Search research articles
Contact Us
Filters
Showing results (21-30 of 329) with videos related to
Page
of 33
Sort By:
Handbook of Experimental Pharmacology
|
August 25, 2012
PAR-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with atherothrombosis
Sergio Leonardi, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
October 24, 2003
The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development
Essam Elsayed, Richard C Becker
American Heart Journal
|
March 30, 2025
Sex as a biological variable: a contemporary perspective
Fatima Farrukh, Richard C Becker
Current Cardiology Reports
|
September 10, 2020
Bridging Anticoagulation with Mechanical Heart Valves: Current Guidelines and Clinical Decisions
Mahboob Ali, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
January 25, 2008
Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass
Maryam Yavari, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
November 12, 2013
The unmet need for philanthropic funding of early career cardiovascular investigators
Tariq Ahmad, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
September 2, 2015
Aspirin dosing in cardiovascular disease prevention and management: an update
Leila Ganjehei, Richard C Becker
Drug Discovery Today
|
July 8, 2014
Factor IXa as a target for anticoagulation in thrombotic disorders and conditions
Dia A Smiley, Richard C Becker
Frontiers in Medicine
|
December 5, 2024
Bridging the gap: strategies for recognizing and managing post-COVID conditions
Muhammad H Khan, Richard C Becker
Current Atherosclerosis Reports
|
October 9, 2025
Current Perspectives on GLP-1 Agonists in Contemporary Clinical Practice from Science and Mechanistic Foundations To Optimal Translation
Husam Abu-Nejim, Richard C Becker
Page
of 33
Search research articles
Search
Showing results (21-30 of 329) with videos related to
Sort By:
Page
of 33
Handbook of Experimental Pharmacology
|
August 25, 2012
PAR-1 inhibitors: a novel class of antiplatelet agents for the treatment of patients with atherothrombosis
Sergio Leonardi, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
October 24, 2003
The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development
Essam Elsayed, Richard C Becker
American Heart Journal
|
March 30, 2025
Sex as a biological variable: a contemporary perspective
Fatima Farrukh, Richard C Becker
Current Cardiology Reports
|
September 10, 2020
Bridging Anticoagulation with Mechanical Heart Valves: Current Guidelines and Clinical Decisions
Mahboob Ali, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
January 25, 2008
Coagulation and fibrinolytic protein kinetics in cardiopulmonary bypass
Maryam Yavari, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
November 12, 2013
The unmet need for philanthropic funding of early career cardiovascular investigators
Tariq Ahmad, Richard C Becker
Journal of Thrombosis and Thrombolysis
|
September 2, 2015
Aspirin dosing in cardiovascular disease prevention and management: an update
Leila Ganjehei, Richard C Becker
Drug Discovery Today
|
July 8, 2014
Factor IXa as a target for anticoagulation in thrombotic disorders and conditions
Dia A Smiley, Richard C Becker
Frontiers in Medicine
|
December 5, 2024
Bridging the gap: strategies for recognizing and managing post-COVID conditions
Muhammad H Khan, Richard C Becker
Current Atherosclerosis Reports
|
October 9, 2025
Current Perspectives on GLP-1 Agonists in Contemporary Clinical Practice from Science and Mechanistic Foundations To Optimal Translation
Husam Abu-Nejim, Richard C Becker
Page
of 33